We typically check B12, folate, thyroid levels, A1C, and others all part of your comprehensive primary care visit
Common side effects Nausea, especially in the first weeks and after a dose increase Mild constipation or diarrhea Reduced appetite and early fullness Occasional reflux and fatigue in the first weeks Most of these are dose-dependent and improve when we slow the titration pace or adjust how you eat
Results revealed significant reductions in tibial nerve cross-sectional area (CSA), an indicator of nerve swelling, with 86% of participants exhibiting reduced CSA and 32% achieving normal nerve morphology [89]
All dosage data below comes from animal studies and clinical observation
In 2017, a group of scientists presented Semaglutide as an effective treatment for obesity
Semaglutide, meanwhile, is a GLP-1 receptor agonist sold by Novo Nordisk under the brand names Wegovy and Ozempic